Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10158160 | 0.91 | PIK3CA (0.51) | MTORPIK3CA | |
| SCHEMBL6892213 | 0.89 | PIK3CA (0.51) | MTORPIK3CA | |
| SCHEMBL6892096 | 0.85 | PIK3CA (0.57) | MTORPIK3CA | |
| SCHEMBL12137703 | 0.85 | MTOR (0.44) | MTORPIK3CA | |
| SCHEMBL10158807 | 0.84 | MTOR (0.75) | MTORPIK3CA | |
| SCHEMBL12774558 | 0.84 | MTOR (0.55) | MTORPIK3CA | |
| SCHEMBL15431014 | 0.84 | PIK3CA (0.75) | MTORPIK3CA | |
| SCHEMBL10156646 | 0.80 | PIK3CA (0.46) | MTORPIK3CA | |
| SCHEMBL10158436 | 0.80 | PIK3CA (0.77) | MTORPIK3CA | |
| SCHEMBL10157757 | 0.80 | PIK3CA (0.77) | MTORPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028952-A1 | 5-ALKYNYL-PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
| WO-2011092198-A1 | 5-ALKYNYL-PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028952-A1 | 5-ALKYNYL-PYRIMIDINES | MKI67, CCNA1, CCNT1 | MTOR 1291/4885PIK3CA 1371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.